Work

Extended-release injection vs sublingual buprenorphine for illicit opioid use in pregnant patients with depression and/or anxiety

Year: 2026

Type: article

Source: Drug and Alcohol Dependence

DOI: 10.1016/j.drugalcdep.2026.113358

Authors: Gerald Cochran, Marcela Smid, Daniel Lewis, Michelle Lofwall, Elizabeth E. Krans, Jennifer P. Wisdom, Davida M. Schiff, Jessica R. Gray, Constance Guille, Mitra Lewis, Viviana E. Horigian, Peter R. Martin, Frankie Kropp, T. John Winhusen

Institutions: University of Utah, University of Cincinnati, University of Kentucky, University of Pittsburgh, Massachusetts General Hospital, Medical University of South Carolina, Emmes (United States), University of Miami, Vanderbilt University

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Drug Abuse Treatment Clinical Trials Network

Awards: Greater Intermountain Node, The Ohio Valley Node of the Clinical Trials Network, The Florida Node Alliance of the National Drug Abuse Clinical Trials Network

OpenAlex ID: W7212285608

FWCI:

Cites: 14

Cited by:

Related to: